At a glance: Departmental Evaluation Plan for the Public Health Agency of Canada, 2024-25 to 2028-29
At a glance: Departmental Evaluation Plan for the Public Health Agency of Canada, 2024-25 to 2028-29
The OAE Departmental Evaluation Plan for PHAC describes the Program Evaluation Division's scheduled work for the five-year period from 2024-25 to 2028-29. The Plan was developed to meet PHAC's commitments under the Policy on Results (2016) which requires that each department prepare a five-year plan, updated annually.
The projects included in this Plan were selected to ensure full coverage of all grants and contributions spending over $5 million annually over a five-year period, prior commitments in Treasury Board submissions, the information needs of program management, program risks, and optimal use of resources. The Departmental Results Framework (DRF), program inventory, and performance information profiles developed by PHAC have formed the basis for this Plan.
This present Departmental Evaluation Plan (DEP) ensures that the Office of Audit and Evaluation (OAE) continues to meet its reporting commitments under the Financial Administration Act (FAA) and any Treasury Board (TB) submission commitments, while also addressing key risks and senior management and program management information needs.
Planning for evaluation
Over the next five years, OAE plans to conduct 31 evaluations that involve PHAC: 23 will focus on PHAC activities and one will examine the activities of both PHAC and Health Canada. There are also seven (7) horizontal evaluations led by OGDs, including two (2) led by Health Canada. A yearly breakdown is provided in Table 1. Table 2 outlines the direct program spending (DPS) by core responsibility for all scheduled evaluations for the next five (5) years.
Table 1 - Number of evaluations per fiscal year
| Lead | 2024-25 | 2025-26 | 2026-27 | 2027-28 | 2028-29 | Total |
|---|---|---|---|---|---|---|
PHAC |
4 |
7 |
4 |
3 |
5 |
23 |
PHAC and HC |
0 |
1 |
0 |
0 |
0 |
1 |
Horizontal (OGD-led) |
1 |
0 |
1 |
4 |
1 |
7 |
Total |
5 |
8 |
5 |
7 |
6 |
31 |
Table 2 - Coverage of direct program spending (DPS)
Note: To obtain detailed estimates on program budgets, annual data for 2024-25 is presented. This financial data was extracted by the Office of the Chief Financial Officer on March 7, 2024. As a result, these budget figures may not fully align with those contained in other corporate reporting documents such as the Departmental Plan, the Departmental Results Report, or the Three-Year Transfer Payment Program Plan.
| Program | Evaluations planned in the next five years | Fiscal year of approval | 2024-25 spending covered by evaluation ($) | Rationale for not evaluating program or spending |
|---|---|---|---|---|
| Core Responsibility | Health Promotion and Chronic Disease Prevention ($387,571,915) | |||
Health Promotion ($280,365,645) |
Nutrition North Canada |
2024-25 |
$335,000 |
|
Preventing and Addressing Family Violence: the Health Perspective |
2024-25 |
$6,250,000 |
||
PHAC's Mental Health Activities |
2025-26 |
$85,240,283 |
||
Maternal and Child Health Programs |
2025-26 |
$82,011,422 |
||
Aboriginal Head Start in Urban and Northern Communities |
2027-28 |
$31,399,393 |
||
Action Plan for Official Languages |
2027-28 |
$2,088,475 |
||
Horizontal Evaluation of the Legalization and Regulation of Cannabis |
2027-28 |
$535,363 |
||
National Action Plan on Violence Against Women and Gender-Based Violence |
2027-28 |
$13,564,417 |
||
Aging, Seniors and Dementia |
2028-29 |
$14,820,008 |
||
Horizontal Evaluation of the Renewed Canadian Drug and Substance Strategy (Including the overdose crisis in Canada) |
2028-29 |
$2,276,514 |
||
Indigenous Early Learning and Child Care Initiative |
N/A |
$41,844,770 |
The timing of the evaluation will be determined during the development of an upcoming Departmental Evaluation Plan. |
|
Chronic Disease Prevention ($39,507,724) |
Healthy Canadians and Communities Fund |
2025-26 |
$29,023,000 |
|
Health Portfolio's Tobacco and Vaping Activities |
2025-26 |
$205,000 |
||
Office of International Affairs |
2025-26 |
$0 |
||
Framework for Diabetes in Canada |
N/A |
$593,510 |
This is a time limited contribution (Start Date: 2021-22 - End Date: 2025-26) with low materiality (approx. $2M). In addition, the National Framework for Diabetes Act calls on the federal Minister of Health to prepare a Report to Parliament on the effectiveness, conclusions and recommendations of the Framework and this process is already underway (due October 2027). |
|
Type 2 Diabetes Prevention Challenge |
N/A |
$4,686,214 |
This is a time limited contribution (Start Date: 2021-22 - End Date: 2023-24) with relatively low materiality (approx. $5M). |
|
Public Health Agency of Canada's (PHAC) Funding of ParticipACTION's Let's Get Moving Initiative |
N/A |
$5,000,000 |
Funding is ending in 2024-25 and was evaluated recently (2023-24). |
|
Evidence for Health Promotion, and Chronic Disease and Injury Prevention ($67,698,546) |
Nutrition North Canada |
2024-25 |
$50,000 |
|
Healthy Canadians and Communities Fund |
2025-26 |
$1,083,000 |
||
Intersectoral Action Fund |
2025-26 |
$3,405,986 |
||
Evidence for Health Promotion Chronic Disease and Injury Prevention, including CPHO report and CCDR |
2026-27 |
$54,213,153 |
||
Impact Assessment and Regulatory Processes (IARP) Horizontal Initiative |
2027-28 |
$212,737 |
||
National Collaborating Centres |
2028-29 |
$3,071,002 |
||
Horizontal Evaluation of the Renewed Canadian Drugs and Substances Strategy (Including the overdose crisis in Canada) |
2028-29 |
$3,663,668 |
||
Integrated Strategy for Healthy Living and Chronic Disease - Pan-Canadian Joint Consortium for School Health |
N/A |
$250,000 |
This funding does not fit with other children's programs and has very low materiality. |
|
Innovative Solutions Canada |
N/A |
$250,000 |
The timing of the evaluation will be will be determined during the development of a future Departmental Evaluation Plan. |
|
| Core Responsibility | Infectious Disease Prevention and Control ($1,003,987,844) | |||
Laboratory Science Leadership and Services ($155,012,883) |
Data Modernization |
2024-25 |
$42,126,334 |
|
Emergency Preparedness and Response |
2024-25 |
$80,500,437 |
||
Infectious Diseases and Climate Change |
2025-26 |
$1,116,689 |
||
Adapting to Impacts of Climate Change (Roll-up of Departmental Evaluations) |
2026-27 |
$0 |
||
Medical Countermeasures Capacity |
2026-27 |
$28,479,434 |
||
Food-borne and Water-borne Enteric Diseases |
2027-28 |
$1,477,968 |
||
Anti-Microbial Resistance |
2028-29 |
$1,252,021 |
||
Public Health Scholarship and Capacity Building Initiative |
N/A |
$60,000 |
This G&Cs program has low materiality and does not fit within any current evaluations. |
|
Communicable Diseases and Infection Control |
Emergency Preparedness and Response |
2024-25 |
$32,582,078 |
|
Health Care-Associated Infections |
2026-27 |
$0 |
||
Respiratory Infectious Diseases |
2027-28 |
$750,000 |
||
Anti-Microbial Resistance |
2028-29 |
$34,838,334 |
||
National Collaborating Centres |
2028-29 |
$973,666 |
||
Horizontal Evaluation of the Renewed Canadian Drugs and Substances Strategy (Including the overdose crisis in Canada) |
2028-29 |
$22,591,217 |
||
Tuberculosis |
2028-29 |
$0 |
||
Sexually Transmitted and Blood-Borne Infections |
2028-29 |
$34,244,000 |
||
Blood Safety |
N/A |
$2,190,000 |
This G&Cs program has low materiality and was evaluated recently (2022-23). |
|
Vaccination Program ($700,464,641) |
Vaccination Program |
2024-25 |
$669,331,963 |
|
Respiratory Infectious Diseases |
2027-28 |
$31,132,678 |
||
Foodborne and Zoonotic Disease ($20,341,025) |
Emergency Preparedness and Response |
2024-25 |
$10,707,721 |
|
Office of International Affairs |
2025-26 |
$0 |
||
Infectious Disease and Climate Change |
2025-26 |
$4,858,466 |
||
Adapting to Impacts of Climate Change (Roll-up of Departmental Evaluation) |
2026-27 |
$0 |
||
Food-borne and Water-borne Enteric Diseases |
2027-28 |
$3,269,901 |
||
National Collaborating Centres |
2028-29 |
$973,666 |
||
Anti-Microbial Resistance |
2028-29 |
$531,271 |
||
| Core Responsibility | Health Security ($273,926,659) | |||
Emergency Preparedness and Response ($237,428,660) |
Emergency Preparedness and Response |
2024-25 |
$236,048,200 |
|
Biosecurity Program |
2025-26 |
$319,623 |
||
Food-borne and Water-borne Enteric Diseases |
2027-28 |
$87,171 |
||
National Collaborating Centres |
2028-29 |
$973,666 |
||
Biosecurity ($17,890,509) |
Biosecurity Program |
2025-26 |
$17,890,509 |
|
Border Health Security ($18,607,490) |
Biosecurity Program |
2025-26 |
$2,007,253 |
|
Border and Travel Health Program |
2026-27 |
$16,600,237 |
||
Page details
- Date modified: